Betnovate Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Concise Prescribing Info

Contents

Betamethasone 17-valerate

Indications/Uses

Cream: Relief of inflammatory & pruritic manifestations of steroid-responsive dermatoses including atopic (infantile atopic dermatitis), nummular (discoid eczema), seborrheic, irritant or allergic contact dermatitis; prurigo nodularis; psoriasis (excluding widespread plaque psoriasis); lichen simplex chronicus (neurodermatitis) & planus; discoid lupus erythematosus; insect bite reactions, miliaria (prickly heat) & adjunct to systemic steroid therapy in generalized erythroderma in adult, elderly & childn >1 yr. Scalp application: Steroid-responsive dermatoses of scalp eg, psoriasis (excluding widespread plaque psoriasis), seborrhoea capitis, inflammation associated w/ severe dandruff.

Click to view Betnovate detailed prescribing information

Dosage/Direction for Use

Cream Adult, elderly & childn >1 yr Apply thinly to affected area once or twice daily for up to 4 wk. Patient who frequently relapse Intermittent dosing (once daily, twice wkly) once acute episode has been treated effectively. Scalp application Apply bid (morning & night). After condition has improved, apply once daily or less frequently.

Click to view Betnovate detailed prescribing information

Overdosage

View Betnovate overdosage for action to be taken in the event of an overdose.

Contraindications

Dermatoses including dermatitis in infants <1 yr. Cream: Untreated cutaneous infections; rosacea; acne vulgaris; pruritus w/o inflammation; perianal & genital pruritus; perioral dermatitis. Scalp application: Scalp infection.

Click to view Betnovate detailed prescribing information

Special Precautions

W/draw gradually if manifestations of hypercortisolism (Cushing's syndrome) & reversible hypothalamic-pituitary-adrenal (HPA) axis suppression are observed; in any spread of infection & administer appropriate antimicrobial therapy. Avoid abrupt w/drawal. Increased risk of systemic effects. Visual disturbance including cataract, glaucoma or central serous chorioretinopathy. Patients w/ psoriasis; history of local hypersensitivity to corticosteroids. Avoid contact w/ eyes. Clean skin before applying fresh occlusive dressing. Do not smoke or use near naked flames. Renal/hepatic impairment. Pregnancy & lactation. Adrenal suppression in infant & childn <12 yr; avoid long-term, continuous use. Elderly. Cream: Higher occurrence of local hypersensitivity reactions & increased risk of local infection when used to treat dermatitis around chronic leg ulcers. Prolonged application to face.

Click to view Betnovate detailed prescribing information

Use In Pregnancy & Lactation

Click to view Betnovate detailed prescribing information

Adverse Reactions

Pruritus, local skin burning/pain.

Click to view Betnovate detailed prescribing information

Drug Interactions

Increased systemic exposure w/ CYP3A4 inhibitors eg, ritonavir, itraconazole.

Click to view Betnovate detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Betnovate detailed prescribing information

Storage